Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

129.07
BATS BZX Real-Time Price
As of 1:37pm ET
 -0.35 / -0.27%
Today’s Change
92.56
Today|||52-Week Range
140.77
+32.57%
Year-to-Date

Today’s Trading

Previous close129.42
Today’s open128.40
Day’s range128.12 - 129.67
Volume24,098
Average volume (3 months)1,753,280
Market cap$28.9B
Data as of 1:37pm ET, 02/19/2019

Growth & Valuation

Earnings growth (last year)+3.06%
Earnings growth (this year)+17.33%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+17.00%
P/E ratio369.4
Price/Sales5.29
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-0.01-0.01%
MYLMylan NV0.000.00%
BMRNBiomarin Pharmaceuti...-2.08-2.21%
REGNRegeneron Pharmaceut...-1.77-0.42%
Data as of 1:38pm ET, 02/19/2019

Financials

Next reporting dateApril 29, 2019
EPS forecast (this quarter)$2.06
Annual revenue (last year)$4.1B
Annual profit (last year)$77.6M
Net profit margin1.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Boston, Massachusetts

Forecasts